Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

AVGR - Avinger Inc


IEX Last Trade
1.1
0   0%

Share volume: 16,647
Last Updated: Fri 30 Aug 2024 09:58:28 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$1.10
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
24%
Profitability 25%
Dept financing 25%
Liquidity 19%
Performance 25%
Company vs Stock growth
vs
Performance
5 Days
-13.95%
1 Month
-14.58%
3 Months
-48.37%
6 Months
-69.67%
1 Year
-85.32%
2 Year
-94.79%
Key data
Stock price
$1.10
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$1.00 - $14.00
52 WEEK CHANGE
-$0.84
MARKET CAP 
2.549 M
YIELD 
N/A
SHARES OUTSTANDING 
2.296 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/24/2024
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$57,563
AVERAGE 30 VOLUME 
$54,659
Company detail
CEO: Jeffrey Soinski
Region: US
Website: http://avinger.com/
Employees: 93
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

avinger, inc. is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems for the treatment of patients with peripheral artery disease (pad). pad is characterized by a build-up of plaque in the arteries that supply blood to the arms and legs. the company’s mission is to radically change the way vascular disease is treated through the introduction of products based on its lumivascular platform, the only intravascular image-guided system of therapeutic catheters available in this market. avinger’s current lumivascular products include the lightbox imaging console, the ocelot family of catheters, which are designed to penetrate total arterial blockages, known as chronic total occlusions, or ctos, and pantheris, the first-ever image- guided atherectomy device, designed to precisely remove arterial plaque in pad patients.

Recent news